Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2

Erin A.S. Clark; Lisa Mele; Ronald J. Wapner; Catherine Y. Spong; Yoram Sorokin; Alan Peaceman; Jay D. Iams; Kenneth J. Leveno; Margaret Harper; Steve N. Caritis; Brian M. Mercer; John M. Thorp; Susan M. Ramin; Marshall Carpenter; Dwight J. Rouse

doi:10.1016/j.ajog.2011.02.061

Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2

Erin A.S. Clark^*, Lisa Mele, Ronald J. Wapner, Catherine Y. Spong, Yoram Sorokin, Alan Peaceman, Jay D. Iams, Kenneth J. Leveno, Margaret Harper, Steve N. Caritis, Brian M. Mercer, John M. Thorp, Susan M. Ramin, Marshall Carpenter, Dwight J. Rouse

^*Corresponding author for this work

Obstetrics and Gynecology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Objective: We sought to evaluate the interaction between repeated-course antenatal corticosteroids and inflammation gene polymorphisms with neurodevelopmental outcomes at age 2 years. Study Design: We conducted nested case-control analysis of a randomized controlled trial of single- vs repeated-course antenatal corticosteroids. Cases had mental and/or psychomotor delay at age 2 years. Controls had normal neurodevelopment. Previous analyses of 125 cases and 147 controls identified 4 inflammation gene polymorphisms associated with neurodevelopmental delay at age 2 years. Results: The interaction between repeated-course corticosteroids and the interleukin (IL)-6 174 genotype with neurodevelopmental delay was significant (P = .046). The IL-6 174 GG genotype was associated with neurodevelopmental delay at age 2 years in the single-course corticosteroid group (odds ratio, 6.47; 95% confidence interval, 1.8622.50). Exposure to repeated-course antenatal corticosteroids abrogated this genotype effect (odds ratio, 1.30; 95% confidence interval, 0.483.54). Results were unchanged after controlling for potential confounders. Conclusion: Repeated-course antenatal steroids may reduce the increased risk of neurodevelopmental delay at age 2 years associated with IL-6 174 GG genotype.

Original language	English (US)
Pages (from-to)	79.e1-79.e5
Journal	American journal of obstetrics and gynecology
Volume	205
Issue number	1
DOIs	https://doi.org/10.1016/j.ajog.2011.02.061
State	Published - Jul 2011

Keywords

antenatal corticosteroids
gene polymorphisms
inflammation
interleukin-6
neurodevelopmental delay

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1016/j.ajog.2011.02.061

Fingerprint Dive into the research topics of 'Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2'. Together they form a unique fingerprint.

Cite this

Clark, E. A. S., Mele, L., Wapner, R. J., Spong, C. Y., Sorokin, Y., Peaceman, A., Iams, J. D., Leveno, K. J., Harper, M., Caritis, S. N., Mercer, B. M., Thorp, J. M., Ramin, S. M., Carpenter, M., & Rouse, D. J. (2011). Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2. American journal of obstetrics and gynecology, 205(1), 79.e1-79.e5. https://doi.org/10.1016/j.ajog.2011.02.061

Clark, Erin A.S. ; Mele, Lisa ; Wapner, Ronald J. ; Spong, Catherine Y. ; Sorokin, Yoram ; Peaceman, Alan ; Iams, Jay D. ; Leveno, Kenneth J. ; Harper, Margaret ; Caritis, Steve N. ; Mercer, Brian M. ; Thorp, John M. ; Ramin, Susan M. ; Carpenter, Marshall ; Rouse, Dwight J. / Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2. In: American journal of obstetrics and gynecology. 2011 ; Vol. 205, No. 1. pp. 79.e1-79.e5.

@article{42c57ef9a4e44f7bb26eca142ddadc54,

title = "Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2",

abstract = "Objective: We sought to evaluate the interaction between repeated-course antenatal corticosteroids and inflammation gene polymorphisms with neurodevelopmental outcomes at age 2 years. Study Design: We conducted nested case-control analysis of a randomized controlled trial of single- vs repeated-course antenatal corticosteroids. Cases had mental and/or psychomotor delay at age 2 years. Controls had normal neurodevelopment. Previous analyses of 125 cases and 147 controls identified 4 inflammation gene polymorphisms associated with neurodevelopmental delay at age 2 years. Results: The interaction between repeated-course corticosteroids and the interleukin (IL)-6 174 genotype with neurodevelopmental delay was significant (P = .046). The IL-6 174 GG genotype was associated with neurodevelopmental delay at age 2 years in the single-course corticosteroid group (odds ratio, 6.47; 95% confidence interval, 1.8622.50). Exposure to repeated-course antenatal corticosteroids abrogated this genotype effect (odds ratio, 1.30; 95% confidence interval, 0.483.54). Results were unchanged after controlling for potential confounders. Conclusion: Repeated-course antenatal steroids may reduce the increased risk of neurodevelopmental delay at age 2 years associated with IL-6 174 GG genotype.",

keywords = "antenatal corticosteroids, gene polymorphisms, inflammation, interleukin-6, neurodevelopmental delay",

author = "Clark, {Erin A.S.} and Lisa Mele and Wapner, {Ronald J.} and Spong, {Catherine Y.} and Yoram Sorokin and Alan Peaceman and Iams, {Jay D.} and Leveno, {Kenneth J.} and Margaret Harper and Caritis, {Steve N.} and Mercer, {Brian M.} and Thorp, {John M.} and Ramin, {Susan M.} and Marshall Carpenter and Rouse, {Dwight J.}",

note = "Funding Information: Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development ( HD21410 , HD27869 , HD27917 , HD27860 , HD27915 , HD34116 , HD34208 , HD34136 , HD40500 , HD40485 , HD40544 , HD40545 , HD40560 , HD40512 , HD36801 ) and M01-RR-000080 from the National Center for Research Resources . Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",

year = "2011",

month = jul,

doi = "10.1016/j.ajog.2011.02.061",

language = "English (US)",

volume = "205",

pages = "79.e1--79.e5",

journal = "American Journal of Obstetrics and Gynecology",

issn = "0002-9378",

publisher = "Mosby Inc.",

number = "1",

}

Clark, EAS, Mele, L, Wapner, RJ, Spong, CY, Sorokin, Y, Peaceman, A, Iams, JD, Leveno, KJ, Harper, M, Caritis, SN, Mercer, BM, Thorp, JM, Ramin, SM, Carpenter, M & Rouse, DJ 2011, 'Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2', American journal of obstetrics and gynecology, vol. 205, no. 1, pp. 79.e1-79.e5. https://doi.org/10.1016/j.ajog.2011.02.061

Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2. / Clark, Erin A.S.; Mele, Lisa; Wapner, Ronald J.; Spong, Catherine Y.; Sorokin, Yoram; Peaceman, Alan; Iams, Jay D.; Leveno, Kenneth J.; Harper, Margaret; Caritis, Steve N.; Mercer, Brian M.; Thorp, John M.; Ramin, Susan M.; Carpenter, Marshall; Rouse, Dwight J.

In: American journal of obstetrics and gynecology, Vol. 205, No. 1, 07.2011, p. 79.e1-79.e5.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2

AU - Clark, Erin A.S.

AU - Mele, Lisa

AU - Wapner, Ronald J.

AU - Spong, Catherine Y.

AU - Sorokin, Yoram

AU - Peaceman, Alan

AU - Iams, Jay D.

AU - Leveno, Kenneth J.

AU - Harper, Margaret

AU - Caritis, Steve N.

AU - Mercer, Brian M.

AU - Thorp, John M.

AU - Ramin, Susan M.

AU - Carpenter, Marshall

AU - Rouse, Dwight J.

N1 - Funding Information: Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development ( HD21410 , HD27869 , HD27917 , HD27860 , HD27915 , HD34116 , HD34208 , HD34136 , HD40500 , HD40485 , HD40544 , HD40545 , HD40560 , HD40512 , HD36801 ) and M01-RR-000080 from the National Center for Research Resources . Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2011/7

Y1 - 2011/7

N2 - Objective: We sought to evaluate the interaction between repeated-course antenatal corticosteroids and inflammation gene polymorphisms with neurodevelopmental outcomes at age 2 years. Study Design: We conducted nested case-control analysis of a randomized controlled trial of single- vs repeated-course antenatal corticosteroids. Cases had mental and/or psychomotor delay at age 2 years. Controls had normal neurodevelopment. Previous analyses of 125 cases and 147 controls identified 4 inflammation gene polymorphisms associated with neurodevelopmental delay at age 2 years. Results: The interaction between repeated-course corticosteroids and the interleukin (IL)-6 174 genotype with neurodevelopmental delay was significant (P = .046). The IL-6 174 GG genotype was associated with neurodevelopmental delay at age 2 years in the single-course corticosteroid group (odds ratio, 6.47; 95% confidence interval, 1.8622.50). Exposure to repeated-course antenatal corticosteroids abrogated this genotype effect (odds ratio, 1.30; 95% confidence interval, 0.483.54). Results were unchanged after controlling for potential confounders. Conclusion: Repeated-course antenatal steroids may reduce the increased risk of neurodevelopmental delay at age 2 years associated with IL-6 174 GG genotype.

AB - Objective: We sought to evaluate the interaction between repeated-course antenatal corticosteroids and inflammation gene polymorphisms with neurodevelopmental outcomes at age 2 years. Study Design: We conducted nested case-control analysis of a randomized controlled trial of single- vs repeated-course antenatal corticosteroids. Cases had mental and/or psychomotor delay at age 2 years. Controls had normal neurodevelopment. Previous analyses of 125 cases and 147 controls identified 4 inflammation gene polymorphisms associated with neurodevelopmental delay at age 2 years. Results: The interaction between repeated-course corticosteroids and the interleukin (IL)-6 174 genotype with neurodevelopmental delay was significant (P = .046). The IL-6 174 GG genotype was associated with neurodevelopmental delay at age 2 years in the single-course corticosteroid group (odds ratio, 6.47; 95% confidence interval, 1.8622.50). Exposure to repeated-course antenatal corticosteroids abrogated this genotype effect (odds ratio, 1.30; 95% confidence interval, 0.483.54). Results were unchanged after controlling for potential confounders. Conclusion: Repeated-course antenatal steroids may reduce the increased risk of neurodevelopmental delay at age 2 years associated with IL-6 174 GG genotype.

KW - antenatal corticosteroids

KW - gene polymorphisms

KW - inflammation

KW - interleukin-6

KW - neurodevelopmental delay

UR - http://www.scopus.com/inward/record.url?scp=79959730625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959730625&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2011.02.061

DO - 10.1016/j.ajog.2011.02.061

M3 - Article

C2 - 21529753

AN - SCOPUS:79959730625

VL - 205

SP - 79.e1-79.e5

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -

Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this